AI Chat
Loading data for TCMD — first visit, this takes a few seconds.

Tactile Systems Technology, Inc.

TCMD · NasdaqGM · USD

22.51 -0.06 (-0.27%)

At close: Sep 15, 2026, 8:00 PM

22.40 -0.49%

After-hours: 7:30 PM

Market Cap
$509.9M
Volume
191K
Next earnings date
May 4, 2026

Tactile Systems Technology, Inc. (TCMD) Stock Price, Analysis & Data

Intrinsic Value

Loading intrinsic value…

Analyst Forecast

Stock Forecasts →

Analyst forecast unavailable

12-month target · n/a analysts

Analyst Consensus: n/a

Interval:1D
Loading candles and signals…

Financial Performance

View financials →

Loading...

Latest Earnings

ReportedVs estimateYoY Change
Revenue$85.70Mn/a+8.61%
EPS$0.36+$0.19+427.27%

Next Earnings

after market closes.

Estimate · Upgrade →

View earnings details →

Metrics

Bid
21.66
Net Income (ttm)
24.9M
0.79
1.07
21.04
15.47
P/B (ttm)
2.28
P/S (ttm)
1.46
Earnings Date
May 4, 2026
Ask
38.01
Volume
191,038
Avg. Volume (20D)
300,620
Open
22.48
Previous Close
22.57
Day's Range
22.25 - 22.63
52-Week Range
13.38 - 37.77
Ex-Dividend Date
n/a

About Tactile Systems Technology, Inc.

View profile →
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. Medical Devices · Healthcare

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Sector Healthcare
IPO Date Jul 28, 2016
Employees 1,086
Stock Exchange NasdaqGM
Ticker Symbol TCMD